Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Interdisciplinary diagnosis and therapy;Chronisch-progressive externe ophthalmoplegie und Kearns-Sayre-syndrom. Interdisziplinäre diagnostik und therapie

Ophthalmologe

Volumn 105, Issue 6, 2008, Pages 550-556

  Wabbels, B ^a   Ali, N ^a   Kunz, W S ^b   Roggenkamper P ^a   Kornblum, C ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Life and Brain Center   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

CPEO; Mitochondria; Mitochondrial DNA; Muscle biopsy; Ptosis

Indexed keywords

EID: 46449088130     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-007-1643-5     Document Type: Article

References (21)

1. Bau V, Zierz S (2005) Update on chronic progressive external ophthalmoplegia. Strabismus 13: 133-142
2. Biousse V, Newman NJ (2003) Neuro-ophthalmology of mitochondrial diseases. Curr Opin Neurol 16: 35-43
3. Chinnery PF, Turnbull DM (2001) Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 106: 94-101
4. Dubowitz V, Sewry CA (2006) Muscle biopsy, a practical approach. 3rd edn. Saunders Elsevier
5. Goto Y, Koga Y, Horai S, Nonaka I (1990) Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J Neurol Sci 100: 63-69
6. Jeppesen TD, Schwartz M, Olsen DB et al. (2006) Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 129: 3402-3412
7. Kornblum C, Kunz WS, Klockgether T et al. (2004) Diagnostic value of mitochondrial DNA analysis in chronic progressive external ophthalmoplegia (CPEO). Klin Monatsbl Augenheilkd 221: 1057-1061
8. Lee AG, Brazis PW (2002) Chronic progressive external ophthalmoplegia. Curr Neurol Neurosci Rep 2: 413-417
9. Lestienne P, Ponsot G (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1: 885
10. Lou HC, Reske-Nielsen E (1976) Letter: Progressive external ophthalmoplegia: evidence for a disorder in pyruvate-lactate metabolism. Arch Neurol 33: 455-456
11. Okulla T, Kunz WS, Klockgether T et al. (2005) Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis. Graefes Arch Clin Exp Ophthalmol 243: 380-382
12. Richardson C, Smith T, Schaefer A et al. (2005) Ocular motility findings in chronic progressive external ophthalmoplegia. Eye 19: 258-263
13. Schaefer AM, Blakely EL, Griffiths PG et al. (2005) Ophthalmoplegia due to mitochondrial DNA disease: the need for genetic diagnosis. Muscle Nerve 32: 104-107
14. Schapira AH (2006) Mitochondrial disease. Lancet 368: 70-82
15. Schoser BG, Pongratz D (2006) Extraocular mitochondrial myopathies and their differential diagnoses. Strabismus 14: 107-113
16. Sciacco M, Prelle A, Comi GP et al. (2001) Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation. J Neurol 248: 778-788
17. Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126: 1905-1912
18. Taylor RW, Schaefer AM, Barron MJ et al. (2004) The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14: 237-245
19. Wiedemann FR, Vielhaber S, Schroder R et al. (2000) Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal Biochem 279: 55-60
20. Zeviani M (2004) Mitochondrial disorders. Clin Neurophysiol Suppl 57: 304-312
21. Zierz S, Wersebe O von, Gerbitz KD, Jerusalem F (1990) Ophthalmoplegia-plus: clinical variability, biochemical defects of the mitochondria respiratory chain and deletions of the mitochondria genome. Nervenarzt 61: 332-339